CRN Origins and Mission

The Louis A. Simpson and Kimberly K. Querrey Center for Regenerative Nanomedicine (CRN) was established in 2012 to advance Northwestern University's leadership position in the emerging field of regenerative nanomedicine. Samuel I. Stupp serves as the center's director and a $10 million gift from the Querrey Simpson Charitable Foundation provides an endowment that supports CRN programs. The CRN operates within the Institute for BioNanotechnology in Medicine and is one of the designated University Research Centers reporting to the Vice President for Research.

The CRN's mission is to foster the early development of new research in regenerative medicine using nanotechnology strategies.

Regenerative nanomedicine is an exciting new field of interdisciplinary research that uses nanoscale technology or materials to seek ways to repair, replace, or regenerate cells, tissues, or organs. The work involves teamwork among researchers in the life, physical, and engineering sciences. The goal of this research is to develop clinical approaches to restore, replace, or enhance biological functions that have been lost due to disease, injury, aging, or congenital abnormalities.

CRN research seeks novel approaches to overcome spinal cord injury, heart and vascular diseases, degenerative joint conditions, neurological disorders, wound healing, bone damage, and organ failure and abnormalities.

Northwestern University press release

CRN catalyzes new research in regenerative medicine using nanotechnology strategies.